# Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests

> **NCT05995808** · NA · UNKNOWN · sponsor: **Sohag University** · enrollment: 30 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **PROCEDURE:** Bone marow biopsy and aspiration
- **DIAGNOSTIC_TEST:** biochemical and heamatological tests

## Key facts

- **NCT ID:** NCT05995808
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09
- **Primary completion:** 2024-08
- **Final completion:** 2025-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05995808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05995808, "Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05995808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*